Press Releases
Press Releases
Clandestine Chemists Diversify to Stay Ahead of Latest Round of Drug Scheduling NMS Labs
The latest data emerging from the Designer Drug Initiative at NMS Labs points to the continuing growth and diversification of the designer drug market. Expanding from a handful of compounds just two years ago, products currently on sale through...
Press Releases
Phyton Biotech Receives CEP for Paclitaxel API Produced by Plant Cell Fermentation
Phyton Biotech, a global supplier of high quality paclitaxel and docetaxel API, has been granted a Certificate of suitability to European Pharmacopeia (CEP) by the European Directorate for the Quality of Medicines and HealthCare for its paclitaxel active...
Press Releases
U.S. Food and Drug Administration Approves Gilead’s Truvada® for Reducing the Risk of Acquiring HIV
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Truvada® (emtricitabine and tenofovir disoproxil fumarate), in combination with safer sex practices, to reduce the risk of sexually acquired HIV-1 infection...
Press Releases
ERBA DIAGNOSTICS, INC. Exhibits at the AACC, American Association for Clinical Chemistry
ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, is pleased to announce that Suresh Vazirani, Chairman of ERBA Diagnostics, will be a key note speaker at the International Marketing Brief (IMB) in conjunction with the AACC....
Press Releases
Merck Highlights Data Presentations at the Alzheimer’s Association International Conference, 2012
Merck known as MSD outside the United States and Canada, announced today presentations at the upcoming Alzheimer’s Association International Conference (AAIC) being held in Vancouver, British Columbia, Canada on July 14-19, 2012. At the conference, Merck...
Press Releases
Osiris Selected by BARDA to Submit Proposal for the Use of Grafix® in Mass Casualty Thermal Burn Injuries
Osiris Therapeutics, Inc. announced today that the company has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to submit a full proposal for a Broad Agency Announcement (BAA) to fund advanced research and development of...
Press Releases
BioAlliance Pharma extends and strengthens the protection of AMEP® with the grant of two patents in the US
BioAlliance Pharma SA , an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces two key achievements in the development of its biotherapy AMEP® with the decision of granting two patents by...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read